
Wempacli 100mg Injection
Marketer
Wembrace Biopharma Pvt. Ltd.
Salt Composition
Paclitaxel (6mg/ml)
Overview Wempacli 100mg Injection
Oncaspar 100mg injection is a chemotherapy agent indicated for breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdosage can lead to severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include nausea, vomiting, and fatigue. Serious side effects such as edema (hands, lips), alopecia, and weight increase are possible. Concomitant medications may mitigate these; however, report any unusual bruising, bleeding, sore throat, mouth sores, or fever. This medication can suppress bone marrow function, increasing infection risk. Regular blood tests to monitor blood cell counts and liver function are essential. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, as well as all current medications, especially those for infections. Interactions with other drugs are possible; comprehensive medication disclosure is crucial. This medication is contraindicated during pregnancy and lactation. Reliable contraception is vital for both partners throughout treatment to prevent conception.
Uses of Wempacli 100mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Wempacli 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Wempacli 100mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Wempacli 100mg Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Wempacli 100mg Injection works:
Oncaspare, a 100mg injectable anticancer agent, disrupts microtubule networks crucial for cancer cell division and proliferation. This action inhibits cancerous growth, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Wempacli 100mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Wempacli 100mg Injection during pregnancy carries a confirmed risk to the fetus and is therefore contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justified when potential advantages outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingUNSAFE
Administration of Wempacli 100mg Injection is contraindicated during lactation. Evidence indicates potential infant toxicity.
DrivingUNSAFE
Wempacli 100mg Injection has potential side effects that might impair driving ability. While driving between treatment cycles isn't inherently prohibited, consider that the medication includes alcohol, potentially making driving inadvisable.
KidneySAFE IF PRESCRIBED
Wempacli 100mg Injection poses no known safety concerns for individuals with kidney impairment; dosage modification is unnecessary. Nevertheless, consultation with a physician is advised for patients with pre-existing kidney conditions.
LiverCAUTION
Wempacli 100mg Injection requires careful administration in individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Wempacli 100mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Wempacli 100mg Injection :
NA
Facts to Know About Wempacli 100mg Injection
Label | Value |
---|---|
Chemical Type | Taxane Derivatives |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Action Class | Taxanes: Antimicrotubule Agents |